These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31107231)

  • 21. Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies - a comprehensive review.
    Singh RK; Dhama K; Chakraborty S; Tiwari R; Natesan S; Khandia R; Munjal A; Vora KS; Latheef SK; Karthik K; Singh Malik Y; Singh R; Chaicumpa W; Mourya DT
    Vet Q; 2019 Dec; 39(1):26-55. PubMed ID: 31006350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccines to Emerging Viruses: Nipah and Hendra.
    Amaya M; Broder CC
    Annu Rev Virol; 2020 Sep; 7(1):447-473. PubMed ID: 32991264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential.
    Monath TP; Nichols R; Tussey L; Scappaticci K; Pullano TG; Whiteman MD; Vasilakis N; Rossi SL; Campos RK; Azar SR; Spratt HM; Seaton BL; Archambault WT; Costecalde YV; Moore EH; Hawks RJ; Fusco J
    PLoS Pathog; 2022 Jun; 18(6):e1010658. PubMed ID: 35759511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters.
    Lo MK; Bird BH; Chattopadhyay A; Drew CP; Martin BE; Coleman JD; Rose JK; Nichol ST; Spiropoulou CF
    Antiviral Res; 2014 Jan; 101():26-9. PubMed ID: 24184127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection.
    Geisbert TW; Daddario-DiCaprio KM; Hickey AC; Smith MA; Chan YP; Wang LF; Mattapallil JJ; Geisbert JB; Bossart KN; Broder CC
    PLoS One; 2010 May; 5(5):e10690. PubMed ID: 20502528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hendra virus and Nipah virus animal vaccines.
    Broder CC; Weir DL; Reid PA
    Vaccine; 2016 Jun; 34(30):3525-34. PubMed ID: 27154393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advancements in Nipah virus treatment: Analysis of current progress in vaccines, antivirals, and therapeutics.
    Mishra G; Prajapat V; Nayak D
    Immunology; 2024 Feb; 171(2):155-169. PubMed ID: 37712243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complementing defective viruses that express separate paramyxovirus glycoproteins provide a new vaccine vector approach.
    Chattopadhyay A; Rose JK
    J Virol; 2011 Mar; 85(5):2004-11. PubMed ID: 21177820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in diagnostics, vaccines and therapeutics for Nipah virus.
    Thakur N; Bailey D
    Microbes Infect; 2019; 21(7):278-286. PubMed ID: 30817995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A highly effective ferritin-based divalent nanoparticle vaccine shields Syrian hamsters against lethal Nipah virus.
    Yin C; Yao YF; Yang P; Liu H; Gao G; Peng Y; Chen M; Lu M; Zhang X; Guo W; Zhang Z; Hu X; Yuan Z; Shan C
    Front Immunol; 2024; 15():1387811. PubMed ID: 38911870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months.
    Pallister JA; Klein R; Arkinstall R; Haining J; Long F; White JR; Payne J; Feng YR; Wang LF; Broder CC; Middleton D
    Virol J; 2013 Jul; 10():237. PubMed ID: 23867060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the pathogenicity of Nipah virus isolates from Bangladesh and Malaysia in the Syrian hamster.
    DeBuysscher BL; de Wit E; Munster VJ; Scott D; Feldmann H; Prescott J
    PLoS Negl Trop Dis; 2013; 7(1):e2024. PubMed ID: 23342177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccines based on the fusion protein consensus sequence protect Syrian hamsters from Nipah virus infection.
    Lu M; Yao Y; Liu H; Zhang X; Li X; Liu Y; Peng Y; Chen T; Sun Y; Gao G; Chen M; Zhao J; Zhang X; Yin C; Guo W; Yang P; Hu X; Rao J; Li E; Wong G; Yuan Z; Chiu S; Shan C; Lan J
    JCI Insight; 2023 Dec; 8(23):. PubMed ID: 37917215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction of a recombinant vaccine expressing Nipah virus glycoprotein using the replicative and highly attenuated vaccinia virus strain LC16m8.
    Watanabe S; Yoshikawa T; Kaku Y; Kurosu T; Fukushi S; Sugimoto S; Nishisaka Y; Fuji H; Marsh G; Maeda K; Ebihara H; Morikawa S; Shimojima M; Saijo M
    PLoS Negl Trop Dis; 2023 Dec; 17(12):e0011851. PubMed ID: 38100536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment of an RNA polymerase II-driven reverse genetics system for Nipah virus strains from Malaysia and Bangladesh.
    Griffin BD; Leung A; Chan M; Warner BM; Ranadheera C; Tierney K; Audet J; Frost KL; Safronetz D; Embury-Hyatt C; Booth SA; Kobasa D
    Sci Rep; 2019 Aug; 9(1):11171. PubMed ID: 31371748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Status of vaccine research and development of vaccines for Nipah virus.
    Satterfield BA; Dawes BE; Milligan GN
    Vaccine; 2016 Jun; 34(26):2971-2975. PubMed ID: 26973068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nipah virus persists in the brains of nonhuman primate survivors.
    Liu J; Coffin KM; Johnston SC; Babka AM; Bell TM; Long SY; Honko AN; Kuhn JH; Zeng X
    JCI Insight; 2019 Jul; 4(14):. PubMed ID: 31341108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A neutralization test for specific detection of Nipah virus antibodies using pseudotyped vesicular stomatitis virus expressing green fluorescent protein.
    Kaku Y; Noguchi A; Marsh GA; McEachern JA; Okutani A; Hotta K; Bazartseren B; Fukushi S; Broder CC; Yamada A; Inoue S; Wang LF
    J Virol Methods; 2009 Sep; 160(1-2):7-13. PubMed ID: 19433112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Nature of Exposure Drives Transmission of Nipah Viruses from Malaysia and Bangladesh in Ferrets.
    Clayton BA; Middleton D; Arkinstall R; Frazer L; Wang LF; Marsh GA
    PLoS Negl Trop Dis; 2016 Jun; 10(6):e0004775. PubMed ID: 27341030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A vaccine targeting antigen-presenting cells through CD40 induces protective immunity against Nipah disease.
    Pastor Y; Reynard O; Iampietro M; Surenaud M; Picard F; El Jahrani N; Lefebvre C; Hammoudi A; Dupaty L; Brisebard É; Reynard S; Moureaux É; Moroso M; Durand S; Gonzalez C; Amurri L; Gallouët AS; Marlin R; Baize S; Chevillard E; Raoul H; Hocini H; Centlivre M; Thiébaut R; Horvat B; Godot V; Lévy Y; Cardinaud S
    Cell Rep Med; 2024 Mar; 5(3):101467. PubMed ID: 38471503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.